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Some Notes on

Abdominal Surgery •
Frank Riggall, M.A., MD.,
F.R.C.P. & F.R.C.S. (Edin.), F.R.F.P.S. (Glas.)

In this interesting and informative paper, Dr. F. Riggall
takes us on an informal and an informative tour through the
common paths of the acute abdomen. He directs us, in his
characteristically lucid manner, into the light of some understanding of the maze of difficulty in diagnosis of the acute abdomen.
SUBJECT is such a common one that I would apologize for
M ypresenting
it to a group of doctors except for the fact that as we
grow older in the practice of surgery we realize we are aided in crises
by being able to recall necessary information. A Latin motto says
"repetitio magister studorium." By constant repetition we master the art
of recalling pertinent information when most vitally needed.
As students we were taught that the history of any illness was of
paramount importance. Years of practic~ tell us that histories are important when they are given by people who can think, who have words
with which to clothe their thoughts, and who have some intention of
telling the truth. In taking histories it is important to keep the questions
simple and a doctor should remember that a man may be known as much
by his questions as by his answers. Diagnosis is made easier in cases of
acute abdomen by obtaining clear, definite answers to the questions:
{1) When did it begin?
{2) Where did it begin?
{3) Where is it now?
( 1) When did it begin? The answer to this question should tell us of a
sudden or gradual onset. If sudden, one thinks of a perforation or an
acute obstruction; if gradual, one thinks of inflammatory processes,
acute or chronic obstructions. A definite answer is important from
another aspect because it should be a surgical t:ule that abdominal pain
of more than six hours duration demands surgery until proved otherwise.
• Paper presented before the Pan American Medical Conference, Miami Beach, Florida,
October 2~, 19:52.
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---Abdominal Surgery-------------(2) Where did it begin? Professor F. R. Miller of St. Andrews University
has shown how helpful the answers to this question can be. He reminds
us that the paired structures of the abdomen have paired nerve supplies
which produce pain on the side of the organ affected. The single structures of the abdomen develop in the midline and have a single nerve
supply which the organs take with them to their adult locations. From
this we see why the pain of gall bladder or appendicular inflammation
should begin in the midline and later pass laterally. This knowledge
tells us why tubo-ovarian or renal pain begins on the affected side and
stays there. This is important in the surgery of approach. It is sometimes difficult, for example, to differentiate between surgical conditions
of the right kidney and the gall bladder. The surgeon may wonder
whether his incision should be made anteriorly or posteriorly. By
eliciting information that the pain began in the midline one can approach
the gall bladder with confidence.
(3) Where is it now? From this query we ascertain if the pain has remained localized as in digestive ulcer penetrating the pancreas; referred as
occurs from loin to groin with ureteral stone; or transferred as happens in
cases of appendicitis where the pain shifts from midline to right lower
quadrant.
Inflammations are the most common causes of acute abdomen
though perforations and obstructions are the most spectacular. The
most common inflammation in the abdomen is acute appendicitis, and
this makes the right lower quadrant a convenient place to begin an
anatomical and pathological tour of the abdom'en.
The pain of appendicitis, for all practical purposes, begins in the
midline around the navel and passes, after a variable time, to the right
lower quadrant. It begins gradually. It increases in severity. The pain
comes before vomiting. When fully developed pain and discomfort
are on the right side. Diagnosis is simple in the male but occasionally
complex in the female. When difficulty of diagnosis arises in the female, it is helpful to recall that right tubo-ovarian inflammation begins
on the right side. Tubo-ovarian inflammation is not usually confined
to one side. There is discomfort or pain on moving the uterus from
side to side or from front to back during bimanual examination. With
right tubo-ovarian inflammation the pain is often worse when the tissues
are stretched by moving the uterus to the left. Right tubal pregnancy
may cause confusion, but the menstrual history should aid greatly in
differentiation. I do not believe it is possible to differentiate between
appendicitis and inflammation caused by the spilling of blood onto the
peritoneum by a ripened, ruptured Graafian follicle of the right ovary.
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In both sexes a stone in the lower right ureter can create difficulty
in diagnosis. Twenty-five years ago studies of the surgical material in
one large clinic in Vienna showed that 10ro of the patients operated
upon for a right ureteral stone had previously undergone an appendectomy without relief. This should not have happened. The stated
questions will produce answers showing that the pain began on the right
side and was referred to either the testicle or the labium majus.
Years ago, Moynihan said that there were two kinds of appendicitis:
the acute and that for revenue only. He was not familiar with a pathological condition which is being recognized with increasing frequency.
The symptoms and signs suggest appendicitis, but they are not quite
dear cut and definite. In self-defense the surgeon opens the abdomen
and finds the appendix normal. He next examines the lower ileum
without finding a Meckel's diverticulitis. Continued search shows the
mesentery studded with inflammed glands which range from pinhead
size to strawberry size. The condition is acute non-specific mesenteric
lymphadenitis whose cause is unknown. Routine appendectomy should
be done and a gland removed for biopsy so that the nature and frequency of the disease may be studied and recorded.
In the right flank acute conditions are almost always muscular in
origin. Rarely, a ureteral stone arrested at the pelvic brim will cause
pain in the flank. Still more rarely, before the characteristic rash appears, the pain of herpes zoster may be felt in the flank .
The biliary tract is the most frequent cause of acute abdominal
symptoms in the right upper quadrant and a stone in the tract is more
coronion than inflammation without a stone. Because the biliary tract
develops embryologically as a budding off from the primitive digestive
tube, the pain of a stone or an inflammation begins in the midline. It
quickly moves to the right hypochondrium - so quickly that accu.rate
answers a-re needed to the question: "Where did it begin?". Acute right
hydronephrosis is a less frequent offender than the biliary tract, and acute
obstruction of the hepatic flexure of the colon comes third in frequency.
In neither of these does the pain begin in the upper midline and pass
laterally.
Acute pain in the epigastrium may be due to affections of the duodenum, stomach, pancreas, spasm of the lower end of the esophagus,
diaphragmatic hernia of the paraesophageal type, and rarely, to coronary
thrombosis. Coronary thrombosis is usually seen by the physician, but
occasionally imitates an upper abdominal catastrophe and it may be very
difficult to differentiate these two conditions. If there is any pain at
all behind the sternum, coronary thrombosis should be remembered, but
in the absence of such pain I have mistaken coronary thrombosis. My
MAY, 1953
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---Abdominal Surgery-------------only comfort is derived from other surgeons telling me that they have
done likewise. A great surgeon told me that sometimes he was only
able to differentiate the two with certainty when early in the course of
an operation for a supposed upper abdominal catastrophe, the patient's
condition under anesthesia rapidly aroused grave concern !
A perforated digestive ulcer of the stomach or the duodenum has
a preceding history of dyspepsia, though the history may be short. Pancreatic pain is rarely confined to the upper midline, usually passes into
the left hyponchondrium and may be severe in the midline of the back
in the lower dorsal region. Spasm of the lower end of the esophagus
gives pain, often severe, behind the xiphoid process. The intensity of
the pain varies from half hour to half hour, is somewhat relieved by hot
drinks and alkalies, is not referred, and is preceded by nervous stress and
strain. Often a history of previous milder attacks can be obtained.
Diaphragmatic hernia is usually easy to diagnose, if one thinks of it, and
may be suspected when relief is obtained by inclining the trunk and
head upwards.
The left upper quadrant of the abdomen is not a frequent site of
acute pain. One should always remember that pancreatic pain is quite
commonly felt in the left upper quadrant, and of course, the characteristic feature of pancreatic pain due to acute inflammation is its severity.
Quite often one-third to one-half a grain of morphine is required to
produce relief. Occasionally, the pain of coronary thrombosis may be
referred to the left upper quadrant, but the diagnostic difficulties of this
imitator have been pointed out. Trauma to the spleen may produce pain
in this area, but the history of trauma alone is enough to alert the surgeon to the possibility of splenic damage. Obstruction of the splenic
flexure causes more difficulty in diagnosis of colonic obstruction than
any other portion of the colon, but when the obstruction has progressed
to the point of producing; acute pain, there is a preceding history of
colonic dysfunction. Renal conditions have been discussed in connection with the right upper quadrant.
In connection with the left flank there is nothing further to add,
but in the left lower quadrant a ureteral stone may be difficult to distinguish from diverticulitis. Indeed it is very important to remember the
possibility of diverticulitis as a source of acute trouble in the left lower
quadrant. Ureteral stone pain will be referred to the bladder, testicle,
or labium majus and will often cause tenderness in the costorenal angle.
The pain of diverticulitis in the early stages is present in the left lower
quadrant with ocassionally reference to the suprapubic area. In the
late stages of diverticulitis perforation may occur through the skin, the
bladder, rectum or vagina, and burrowings of the pus in these directions
will produce some alteration in the picture.
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In the hypogastrium a distended bladder or a degenerating uterine
fibroid may produce pain. A catheter solves the first problem and a
bimanual examination the second.
In all cases of .acute abdomen the ordinary and extraordinary sites
of hernia must be examined. The ordinary sites are inguinal, femoral,
and umbilical. The extraordinary sites are incisional, obturator-high
up on the medial surfac~ of the thigh, gluteal-in the buttock, lumbar
-over the iliac crest, and perineal.
It will be seen that the problem of the acute abdomen is U$ually
solved by weighing and judging the evidence. In cases where doubt
remains we should remember the ancient myth of Pandora and the box.
From it we learn that after Pandora opened the box and loosed upon
the world Furies, Sorrows and Pestilences, she hurriedly shut the lid.
One condition was left inside. That condition was Hope, and where
doubt remains the surgeon should open the abdomen and look in.
It is safer to operate and see than to wait and see.

8~ iMIU •••
Diagnosis : a physician's forecast of disease by the patient's pulse and purse.
Erudition : dust shaken out of a book into an empty skull.
Homeopathist: the humorist of the medical profession.
Belladonna: in Italian a beautiful lady; in English a deadly poison. A striking
example of the essential identity of the two tongues.
Cynic: a blackguard whose faulty vision sees things as they are, not as they
ought to be.
Idiot: a member of a large and powerful tribe whose influence in human affairs
bas always been dominant and controlling.
Prescription : a physician's guess at what will best prolong the situation with
least harm to the patient.
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Functional Uterine Bleeding:
W.

J. Hannah, '53

Functional uterine bleeding is not uncommonly found in
practice and it confronts the practitioner with a challenge in diagnosis and management. W. J. Hannah, in this excellent review
of the subject, discusses the various forms of therapy and their
advantages and disadvantages.
functional uterine bleeding, in general, refers to that type
T HEof TERM
abnormal uterine bleeding which has no organic basis.
It is estimated that this type of bleeding comprises from 15 to 201o
of all bleeding seen in gynecologic practice, so that the diagnosis and
proper management of this condition constitutes a major challenge to
the practising physician.
Oinical Olaracteristics
The bleeding may be one of three types:
1. Menorrhagia-this may be a moderate excess of menstruation, or
may be severe enough to produce profound circulatory changes and
gross anemia; the duration of the period is usually prolonged as
well as the per minute flow.
2. Metrorrhagia-irregular bleeding is quite characteristic of this condition.
3. Meno-metrorrhagia-most cases display some degree of both pro,
fuse bleeding and irregularity.

Functional uterine bleeding may occur at any age during the childbearing years and occasionally occurs outside the reproductive period.
Generally speaking 55 to 60% of all cases take place between the ages
of 35 to 50; wro of cases are seen about the age of puberty; the remainder are distributed uniformly throughout the intervening period of
menstrual life.
Pain may or may not be associated with the bleeding, but it is not
a characteristic feature.
Physiologic Processes
Normal Physiology
To properly appreciate the mechanisms underlying this morbid
condition, a brief review of the factors controlling normal menstruation
should be considered.
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In this regard, the anterior pituitary and the ovary are the prime
movers, and the endometrium merely a target organ; after each period
is over and the endometrium has been shed, the follicle-stimulating hormone from the pituitary stimulates the formation of Graafian follicles
in the ovary; these in turn produce estrogen which, among other things,
produces proliferative changes in the endometrium; when the blood
estrogen has reached a critical level, the production of F.S.H. is inhibited
and in its place, luteinizing hormone is liberated causing first, the rupture of one Graafian Follicle (i.e. ovulation) and secondly, the formation
of a corpus luteum in its place; the corpus luteum under continued
stimulation of L.H. liberates progesterone, which among other things,
creates secretory changes in the endometrium. Roughly fourteen days
after ovulation, the blood levels of estrogen and progesterone drop to
a low level and one or two days later the endometrium sheds. According to Markee, this shedding of the endometrium is due to a spasm of
the spiral arterioles supplying the endometrium causing an ischemia
followed by slough. This normally lasts from three to six days, at the
end of which time the cycle begins again.
Thus, it can readily be seen that the normal functioning of menstruation de.p ends upon a delicate hormonal balance between the anterior
pituitary and ovary, as well as the relative receptivity and refractivity
of th uterine endometrium. This latter factor is difficult to assess and
undoubtedly varies in different individuals.
Abnormal Physiology
In a vast majority of cases of functional uterine bleeding, the observed phenomena are to be explained by a failure of ovulation with an
abnormally persistent estrogen output. Since no corpus luteum is formed
no progesterone is produced and thus not only is a secretory type of
endom·e trium prevented from being formed , but also the excretion of
estrogen is delayed by virtue of the fact that no progesterone is present
to help bring about its breakdown by the liver into its excretion products, estrone and estriol; thus with a persistently high level of estrogen
in the blood, a hyperestrin or hyperplastic "Swiss-cheese" type of endometrium is formed and in most cases, this is the type of endometrium
found on curettage. If we accept Markee's concept that endometrial
bleeding occurs when the blood level of estrogen either falls below a
critical upper level, or is raised above a critical lower level, that is, there
is a rather limited intermediate range of blood estrogen level during
which endometrial bleeding occurs and outside that range no bleeding
occurs, and there is considerable evidence to support this concept, then
the bleeding which occurs in the anovulatory type of functional bleeding
is explained by the estrogen level undergoing temporary drops into the
MAY,
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- - -,Uterine Bleeding - - - - - - - - - - - - - - bleeding range by means of an inhibition of the pituitary gonadotrophic
fun ction by a certain high level of estrogen, which varies in different
women.
Not all functional bleeding, however, can be explained by failure
of ovulation; in a smaller percentage of cases, ovulation has occurred
as proven by the demonstration of a secretory or progestational type of
endometrium in the curettings of such patients. McKelvey suggests that
the bleeding here may possibly be due to the production of an abnormal
form of progesterone or a prolonged progesterone effect.
In an even smaller percentage of cases, an atrophic endometrium
may be the site of functional bleeding. The bleeding here could be
explained on the basis of temporarily raising a low estrogen level up
into the " bleeding range" or may be due to an endometrium which is
refractory to the growth effects of estrogen, but nevertheless is sensitive
to the fluctuations in estrogen brought about by the ovarian-pituitary
interplay.
Diagnosis
Many gynecologists agree that one of the most difficult things
about functional uterine bleeding is the establishment of an accurate
diagnosis.
The diagnosis is best made by exclusion only. All studies, both
local and general should be exhausted so that organic disease of the
body in general, or of the pelvic organs in particular, may be ruled out.
General studies should include investigation for any endocrine dysfunction , especially thyroid disease; for any blood dyscrasias, such as
leukemia, aplastic anemia, and thrombocytopenic purpura.
Locally, apart from a thorough pelvic examination, the most important single diagnostic aid at our disposal is a diagnostic curettage.
In any case of abnormal, persistent uterine bleeding, this should be
done, and in many cases of organic uterine disease, this is the only means
of making the diagnosis; if organic disease can be definitely excluded
by gross and microscopic examination of the curettings then a diagnosis
of functional bleeding may safely be made. In this case, the endometrium
is usually of the proliferative or hyperplastic type, but as was said
earlier, it may correspond to that found in any of the normal menstrual
phases.

Treatment
Like any abnormal condition, the exact mechanism of which is imperfectly understood, the treatment has been unusually varied; therefore,
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a review of the various methods used will be presented with emphasis
placed on the more effective methods.
First of all the treatment may be divided up into two broad groups:
A. General M easures
1. Sometimes these patients have lost a considerable amount of
blood, so that a transfusion may be necessary.
2. Secondary anemia is frequently seen therefore iron should be
given.
3. Any protein deficiency in the diet should be corrected.
4. Vitamin B complex in large doses is recommended by some
authorities. This aids liver function which appears to be impaired in this condition.
5. Thyroid therapy-Novak and others report that only in a very
few cases does thyroid deficiency play any part in the pathogenesis of this type of bleeding. In spite of this, thyroid extract
is of great value not only in functional uterine bleeding, but also
in most functional female disorders. It is placed under general
measures because its use in most cases is empirical and it exerts
no specific action unless there is actual hypothyroidism in which
case its value is obvious.

B. Specific Therapty
Specific treatment may itself be divided into two important groups :
(a) Treatment in the younger age group and during reproductive
years.
(b) Treatment at or near the menopause.

(a) Treatment in the Younger Patients
It must be borne in mind, first of all, that irregularity and excessive
menstrual flow at the menarche is far from uncommon and that a large
percentage of these cases will recover spontaneously; thus it becomes
the responsibility of the physician to decide when the condition has
ceased to be simply a slight aberration of a normal phenomenon and
has become definitely pathological. This may sometimes be difficult
to decide, but in any case of doubt, correct diagnosis and treatment
should be started at once.
1. Curettage--Apart from its diagnostic value, curettage has a very

prominent therapeutic effect. Jones in a series of cases in 1949 reported that curettage provided a complete cure in 42«7'0 of his cases.
Even if a full cure is not obtained a large number of patients resume
normal cycles for a period of months at the end of which time the
curettage may be repeated.
MAY, 1953
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---Uterine B l e e d i n g - - - - - - - - - - - - - - It is of great value when the patient is bleeding profusely and
should be done as soon as possible - it rarely fails to check what
might otherwise prove to be a disastrous haemorrhage although such
cases are rather uncommon.
Taylor, of the University of Colorado, suggests that the rationale
of curettage as a therapeutic measure is that the target-organ, the
uterus, is not fitting into the pattern and by removing the endometrium we might then expect the regrowth of a more satisfactory
participating end-organ.
2. Hormonal Treatment-Even though the underlying cause of this con-

dition is in the pituitary, as yet attempts to correct it at this level
have been. disappointing, so it must be attacked at the ovarian level.
(i) Estrogens
The rationale for the use of estrogen therapy becomes obvious
when we remember that if we raise the blood estrogens to a certain
level the endometrial bleeding will cease; in addition, estrogens inhibit the production of the pituitary F.S.H. and so reduces ovarian
stimulation, and thus . indirectly cause follicular atresia. This, in
effect, produces a temporary castration which is the same effect
created by irradiation with none of the obvious dangers of the latter.
Estrogenic therapy is one of the most popular means of managing benign uterine bleeding, but in recent years E. C. Hamblen of
Duke University has combined estrogens with progesterone to obtain
a natural cyclic effect. This method of treatment will be discussed
shortly.
Estrogens are probably the best single hormonal treatment for
that type of bleeding in which ovulation has occurred.
(ii) Progesterone
This hormone acts by reducing estrogenic activity, by stopping
the proliferative changes in the endometrium, and inducing secretory
changes, thus producing a more physiological endometrium.
It is used either intramuscularly or sublingually and has produced good results in a large number of cases. Its chief disadvantage
is its expense because it must be given in fairly large doses.

(iii) . Cyclic Therapy
This implies a regulated use of both estrogen and progesterone;
the idea behind this form of treatment is to "chemically prime" the
pituitary, ovary, and endometrium to resume a normal cyclic activity
and its use in finding increasing favour throughout the North
American continent.
124
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The m.ethod of treatment as originally recommended by Hamblen is to begin with an estrogen, such as estrone sulphate, administering 7.5 mgm. daily until the bleeding ceases. This dose is increased by 50«J'o if the bleeding has not definitely decreased by the
third day of treatment. The estrogen is maintained for 20 days;
during th last 10 days, 60 mgm. of oral progesterone is given daily.
Withdrawal bleeding then occurs and on the 4th or 5th day of bleeding, the course is repeated again with half of the dosage used. He
states that three or four such series usually restores normal function.
Since this form of therapy was introduced several modifications have
come into vogue which include the use of diethyl stilbestrol and
sublingual or intramuscular progesterone, which provides cheaper
and more effective treatment. Many gynecologists withhold the
progesterone until the end of the estrogen course. However, the
principle remains essentially the same.
( iv) T esto·sterone
This hormone inhibits the pituitary, inhibits follicular production, and produces atrophy of the endometrium and its vascular bed.
It has produced favourable results in many cases if the dosage is not
too high-Novak gives from 30 to 50 mgm. a week. However,
there is the ever-present danger of masculinizing changes which in
some instances may be permanent.
(v) Anterior Pituitary-like Hormones
Theoretically,. the gonadotropins should be the most rational
form of therapy since it is a disturbance in the hormonal output of
the pituitary which is at the root of the trouble; however,.these hopes
have not been sustained and these hormones are not commonly used.
3. Protamine Sulphate and Toluidine Blue-Rumbolz of the University
of Nebraska reports excellent results using these compounds; according to him, an inhibitor to clotting is present in this condition
and these substances neutralize this inhibitor. It is too early yet to
assess the value of this treatment.
4. Psychic Management-It is essential, especially at puberty, to reassure these patients, to explain to them the nature of their condition,
and that it may persist for some time, but that the prospect of complete
cure in a relatively short time may reasonably be expected.
5. Radical Methods-The use of radiation, or surgical correction of this
condition in younger patients cannot be too strongly condemned, unless, despite all conservative methods of management the patient's
condition continues to deteriorate. In such cases light radiotherapy
MAY.;
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---Uterine Bleeding - - - - - - - - - - - - - - to the ovaries may be tried in the hope of checking the condition;
even light dosage may produce irreversible changes in sensitive
ovaries.
Complete irradiation of the ovaries or hysterectomy should be
reserved for those very few cases where all other methods including
time fail.

(b) Treatment At or Near the Menopause
The management of the condition is much simpler in this age
group, since it is not essential to preserve either ovarian function or the
uterus; thus the treatment, after diagnosis is made resolves itself, in
general, into one of the two methods:
1. Radiation-Many workers feel this is the treatment of choice, since

it obviates the inconvenience and discomfort of surgery and is, in
most cases, simple to perform and is very effective.
It may be used in one of two ways :
(i) Irradiation of ovaries-some ovaries are unusually refractive to
radiation and may cause further bleeding.
(ii) Intra-uterine radium-Hundley and workers at the University of
Maryland are very enthusiastic about this form of treatment, but
most gynecologists feel that it has a very limited use and there is
always the danger of the radiation producing malignant changes in
the already hyperplastic endometrium.
2. Surgery-Surgical removal of the uterus is favoured by a large num-

ber of gynecologists. Vaginal hysterectomy, in competent hands, is
a relatively simple and safe op_eration and it has the special merit
of not only completely curing the condition but at the same time
removing a potential focus of carinoma.
Opinion is divided on the question of radiation versus surgery.
However, it is generally felt that hormonal treatment is not as good as
either of these two in this group-it is expensive and many feel that it
may definitely be carcinogenic, though opinion here is again divided . .
Snonary
A review of the physiological processes underlying functional
uterine bleeding has been presented, emphasizing that most cases are of
the anovulatory type, but a small percentage may show normal menstrual, or even atrophic endometrial changes.
The diagnosis is made by exclusion of any organic disease by means
of history, physical examination, pelvic examination and D. & C.
126
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The management is divided up into:
(a) General Measures
(b) Specific Measures
The specific measures are further divided into:
(a) Treatment of younger age group.
This is broken down into:
1. Therapeutic curettage.
2. Hormones - those which appear to be most effective
are estrogens and progesterone, either singly, or combined as cyclic therapy.
(b) Treatment at or near the Menopause-the methods here
are:
1. Radiation.
2. Surgery.
The advantages and disadvantages of each form of therapy has been
considered.
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Autonomic Drugs:
with Special Reference to Adrenergic Blockade*
C. W. Gowdey, B.A., M.Sc., D.Phil. (Oxon.).

This clinical evaluation of the numerous adrenergic blocking
agents wiii be of considerable interest to ali. Dr. Gowdey, in
reviewing the recent literature, has presented a concise, critical
review of the value of chemical sympathectomy in the treatment of
peripheral vascular disease.
CLINICAL application of drugs affecting the autonomic nervous
T HEsystem
is increasing rapidly as newer, more potent, more specific
synthetic drugs are introduced. The number and complexity of these
compounds, and the confusion caused by the numerous trade names,
and by premature enthusiastic claims, make one wonder whether the
pendulum has swung too far away from Osler's tenet that the practitioner needs only ten drugs.
Certain physiological and anatomical aspects of the autonomic
nervous system are important for an understanding of the action of
autonomic drugs. One of the chief differences between the sympathetic
and parasympathetic divisions is in the extent to which their fibres
ramify. A preganglionic sympathetic fibre may traverse a considerable
distance of the sympathetic chain and pass through several ganglia before
it finally synapses with a postganglionic neurone; it also synapses with
a large number of postganglionic fibres. In this .way the sympathetic can
discharge as a unit, and does so in circum~tances of r~ge and fright. The
parasympathetic system, on the other hand, has its ·terminal ganglia very
near or in the organs innervated, and therefore is· more limited and discrete in its discharge of impulses. Cannon< 1 > summarized the distinctions
between the two parts of the autonomic nervous system in this way, "The
sympathetics are like the loud and soft pedals, modulating all the notes
together; the cranial and sacral innervations are like the separate keys."
A clear understanding of the response of various organs to autonomic
nerve impulses makes it possible to anticipate the actions of many drugs.
Generally speaking, the sympathetic and parasympathetic are physiological antagonists; if one system inhibits a certain function, the other
augments it. Many organs are innervated by both divisions of the
autonomic, and the level of activity at any instant is the balance of the
*Article received for publication, January, 1953.
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results of the two influences. The activity of one system is usually intensified by removal or paralysis of the other. Acetylcholine will faithfully imitate the effects of parasympathetic nerve stimulation, whereas
belladonna alkaloids will prevent these effects. In the same way,
Adrenaline and Noradrenaline imitate most, if not all, of the effects of
sympathetic nerve stimulation.
Clinicians have long made use of drugs such as Physostigmine and
Pilocarpine, which imitate parasympathetic effects. Newer synthetic parasympathomirnetics include Methacholine (Mecholyl), Carbachol (Doryl),
Neostigmine (Prostigmin), D.F.P. ( di-isopropyl fluorophosphate) and
T.E.P.P. (tetrarethylpyrophosphate) . Many of the sympathomimeticshave
also found their way into clinical medicine since the systematic investigation by Barger and Dale <2 > in 1910 of sympathomimetic amines.
A great deal of research has been done to develop more powerful compounds with longer-lasting and less toxic effects. As a result, dozens of
drugs with more or less sympathetic-like activity have appeared on the
market. The differences among them are often more apparent from
advertisements than from pharmacological investigation. A few of the
newer, more popular synthetic sympathornimetics are: Phenylephrine
(Neosynephrine) , Hydroxyamphetamine (Paredine), Naphazoline (Privine), Phenylpropanolamine (Propadrine) , and Methoxamine (Vasoxyl).
Certain members of the sympathomimetic amine series have properties
other than vasoconstriction which have been utilized clinically. An
example of this is found in Amphetamine (Benzedrine) and Methamphetamine (Desoxyephedrine, Desoxyn) , which are used a great deal as
central nervous system stimulants. Another example is Isopropylarterenol
(Isuprel, Aludrine) which actually causes vasodilatation; it is a powerful
bronchodilator, however, and is used in the treatment of asthma.
The parasympathetic blocking agents such as Atropine and Hyoscine
have been used clinically for many years. Certain synthetic drugs such
as Homatropine, Trasentine, Syntropan, and Methanthaline (Banthine)
are also used now in the treatment of parasympathetic hyperactivity.
Evelyn states in his review on autonomic drugs(3l that the short-term
effects of Banthine have been fairly well established in the treatment of
duodenal ulcer. Relief of pain occurs in about 90% of cases, usually
within the first two days of treatment. He feels that careful, controlled
studies over long periods will be required, however, to decide whether
the percentages of unsuccessful results will be significantly smaller on
Banthine than on conventional therapy.
Until recently the effects of the sympathetic nervous system could
be annulled by various means, but not by specific blockade, as the parasympathetic could be by the belladonna drugs. It is true that Dale demonstrated adrenergic blockade experimentally by an ergot preparation in
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of the sympathetic nervous system required concentrations toxic to the
human. Thus Dale's blockade with ergot remained a laboratory curiosity - a useful tool for pharmacologists, but of no clinical value.
Sympathetic activity could be abolished, temporarily, by surgical procedure, and was antagonized by such central nervous system depressants
as barbiturates and also by local anesthesia of the nerve trunks.
"Chemical sympathectomy" (or "medical sympathectomy") is now
possible, and it is proposed to review this part of autonomic drug action
in somewhat more detail. Chemical sympathectomy can be produced in
two ways: first, by blocking the sympathetic ganglia, and second, by
blocking the sympathetic effector cells in the end-organ. Sympathetic
ganglia are effectively blocked by Tetraethylammonium ion (Etamon),
and by Penta- or Hexamethonium ion (Cs, Vegolysen). These compounds
are being investigated clinically in hypertension and peripheral vascular
disease. Although Tetraethylammonium does cause autonomic blockade, <5> this effect seems to be too transient to be valuable in the diagnosis
or treatment of vascular spasm, and TEAC can only be given parenterally.
Paton and Zaimis< 6> investigated the methonium salts pharmacologically,
and their results led directly to clinical trials of these agents. Arnold
and Rosenheim(7> showed that an intravenous injection of 25 to 100 mg.
of Hexamethonium Bromide produced a rapid and sometimes excessive
fall of blood pressure in hypertensives in the horizontal position. This
hypotensive effect lasted at least an hour, but postural hypotension still
occurred after several hours. Many reports have come out in the past
two years on the use of methonium compounds in hypertension. Some
investigators, such as Locket, Swann, and Grieve,<&> were not enthusiastic.
They tried both Pentamethonium and Hexamethonium Bromide in 34
cases of persistent hypertension. Before starting the drugs, each patient
was given two weeks' initial observation, routine treatment, and rest in
bed. In every case the methonium compounds (given I.M. and orally)
were hardly any more effective in lowering blood pressure than the bed
rest period. When the drugs were given orally to these cases as outpatients, they failed to lower or maintain a low blood pressure. One
death and three probable cases of bromide intoxication, probably attributable to the drug, were reported . They believe that the sedative effect
of the bromide part of the compound, aided by ancillary factors, was one
of the important factors in the subjective improvement of the patients.
Hexamethonium is now available as the bitartrate salt to overcome the
objection to the bromide ion. Others such as Smirk and Alstad <9>;
Frankel <10 >; Freis< 11 >; and Turner< 12 > reported that the methonium compounds are valuable in the reduction of hypertension. Smirk and Alstad
conducted 150 tests on hypertensives of varied etiology and on 53 patients
treated for 2 to 14 months, and concluded<9 > that these drugs are the most
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effective and generally applicable hypotensive agents. Blood-pressure
reduction was associated with relief of dyspnea, pulmonary congestion,
headache, papilledema, and retinal exudates (11 patients had malignant
hypertension). Treatment must be individualized and the patients
selected carefully; great blood-pressure reductions may be inadvisable in
patients with much cerebral or coronary sclerosis because of the danger
of thrombosis, etc. They state that, "attempts at treatment which do not
take account of individual responsiveness to the drugs, postural hypotension, the effect of salt intake, the acquisition of tolerance, and numerous other factors will flounder between the dangerous and the ineffectual." Freis' experience< 11 > confirmed that of Smirk; if properly administered Hexamethonium is an effective agent for reducing blood pressure
in the majority of cases, including those with malignant hypertension;
oral administration is not so reliable as parenteral; and the patient or a
member of the family can be taught to administer the injections and
record the blood pressure in the home, thus making long-term therapy
feasible. Many clinicians might argue the advisability of having hyper. tensives take their own blood pressures. Frankel (Io) was quite enthusiastic, and also considered that oral administration was much l'ess effective than intramuscular. Turner<12l felt that no patient should be submitted to surgical sympathectomy for hypertension until a thorough trial
with methonium had been made; likewise every patient with malignant
hypertension should be similarly treated.
Besides the relatively rapid development of tolerance, all of the
reports stress the potential dangers, warn against indiscriminate treatment, and recommend that the initial assessment be made in hospital.
The dangers of postural hypotension, of coronary or cerebral thrombosis in patients with advanced arteriosclerosis, and of impaired renal
function from lowering the blood pressure are very important considerations. Neither the methonium compounds nor other ganglionic blocking
agents will block the sympathetic ganglia, without also blocking the
parasympathetic. Thus, besides the undesirable postural hypotension,
etc., mentioned above, other side effects, e.g., dry mouth, constipation,
blurring of vision and photophobia referable to parasympathetic blockade
are often observed. In fact, Hexamethonium has been used in this regard
to treat the pain of gastric ulcer. Although the final answer is not known
regarding the use of methonium compounds in hypertension the literature suggests that most clinicians will limit their application to severe
cases (e.g., malignant hypertension) , to short-term disorders (toxemia
of pregnancy); to dangerous episodes {hypertensive encephalopathy),
and to relief of symptoms such as headache due to hypertension. Only
a long and carefully controlled trial can tell whether methonium may
reasonably be given to young patients with benign hypertension, with a
view to postponing cardiovascular or renal lesions<13l.
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---Autonomic Drugs - - - - - - - - - - - - - - - On theoretical grounds, chemical sympathectomy by blockade of the
sympathetic effector cells would appear to be preferable, but the problem
is not yet resolved. Various terms such as "adrenergic blocking agent,"
"adrenolytic" and "sympatholytic" have been used to describe this peripheral action. Nickerson <14 > prefers the expression ·:adrenergic blocking
agent," because he points out that neither nerve ending nor chemical
mediator nor effector cell is "lysed" by these compounds. The other
words are, however, still widely used. True adrenolytic action, ·i.e.,
chemical destruction of adrenaline, is shown by such oxidizing agents
as potassium permanganate. All adrenergic blocking agents appear to be
more effective in blocking the action of circulating sympathomimetics
than they do against sympathetic nerve stimulation, but the difference is
probably a question of dosage and permeability, not of fundamental
mechanism of action. Jang <u> found that a whole host of compounds
could be either synergistic or antagonistic to adrenaline, depending on
their concentrations.
Other naturally-occurring adrenergic blocking agents besides ergot
are the alkaloids Yohimbine, Corynanthine, and Apocodeine, but these
are not used today in therapeutics. The first synthetic blocking agents
of any importance were the benzodioxane derivatives prepared by
Fourneau. The best known and most active of this series are 883F and
933F (the "F" for Fourneau; the latter is called Piperoxan (Benodaine) .)
In 1939 Hartmann and Isler0 6l described a series of imidazoline compounds, some of which were sympathomimetic and others were blocking
agents. Further laboratory work< 17 • 18 • 19l showed that Benzazoline
(Prisco line) was a powerful adrenergic blocking agent. Swiss pharmacologists continued to work with the imidazoline nucleus, and finally
synthesized Regitine, which was introduced into Canada only this year.
Other Swiss workers hydrogenated the ergot alkaloids ergocornine, ergocristine, and ergokryptine in 1943<20 >; these three are marketed as Hydergine, which contains dihydroergocornine, dihydroergocristine, and
dihydroergokryptine in equal proportions, and also separately. Dibenamine is an American preparation, a synthetic nitrogen mustard derivative,
first described by Nickerson and Goodman in 1945<21 >. A new potent
derivative of this series, Dibenzyline, is at present being tested clinically.
Benzodioxane derivatives show a wide range of activity; some (883F)
block primarily the responses to circulating sympathomimetics <22 > <23l ,
while others {933F) can also block sympathetic nerve activity. The blockade by this series is rather weak, and they have other pharmacological
properties: cardiovascular excitation of central origin, coronary constriction, cardiac depression, analgesia, ganglionic excitation and adrenaline
secretion<HJ . Currently, of this group, only 933F is receiving extensive
clinical trials, mostly as an aid in diagnosing tumors of the adrenal
medulla. Goldenberg, Snyder and Aranow< 24 l have worked out a dosage
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range in which the drug produces an insignificant or moderate elevation
in blood pressure in normal subjects. A similar amount produces a
blood-pressure reduction if patients ~av e hypertension associated with a
pheochromocytoma.
·Priscoline and the chemicaJly-related Regitine are adrenergic blocking agents which both act peripherally. Besides inhibiting the effects
of circulating sympathomimetics, they will in sufficient dosage also block
sympathetic vasoconstriction. The pharmacological properties of Friscoline have been described by Meier and Mueller<17 >, Ahlquist, Huggins
and Woodbury <18 >, and by Gowdey<19 >. Grimson, Reardon, Marzoni and
Hendrix<m described its clinical use in peripheral vascular diseases and
in hypertension. Priscoline caused slight and inconsistent increases in
pulse rate, cardiac output, and arterial blood pressure. Both normal
patients and those with ischemic extremities showed increased cutaneous
blood flow; Priscoline has vasodilating activity beyond its adrenergic
block action(l 9l . Grimson et aJ reported that single doses, with few exceptions, produced changes in the circulation of limbs equivalent to those
produced by sympathetic block or sympathectomy. Results in treatment
of Raynaud's disease were encouraging and unless evidence of toxicity
or tolerance developed, sympathectomy was no longer recommended by
Grimson et al. They also reported encouraging results in treating vasospastic ischemia extremity problems and causalgia states. Priscoline has
been tried in most peripheral vascula r disorders, especially in Europe.
Attempted treatment of hypertension by Priscoline yielded few encouraging results, and use of a Priscoline test did not aid in prediction of the
results of sympathectomy. One of the advantages of Priscoline over some
of the other blocking agents is that it may be given intravenously, intramuscularly, or orally. Occasional side effects of Priscoline are orthostatic hypotension, tachycardia, nausea and goose flesh ; the insulin requirement of diabetics may be reduced. Beckman< 26> thinks Priscoline
should be used very cautiously in peptic ulcer (because it increases acid
gastric secretion) and in coronary disease. Small doses of Regitine given
I.V. or orally will lower the blood pressure<21l, and may aid in the diagnosis of pheochromocytoma.
Rothlin <28 > has shown that Hydergine (the combination of three
hydrogenated ergot alkaloids) instead of causing contraction of smooth
musculature and vasoconstriction as do the parent compounds, actually
dilates vessels and protects the effector organs from harmful adrenergic
stimuli. The vasodilatation is thought due to both an action on the vasomotor centre and· to a direct action on vessels. Bradycardia, due to a
central action, is partly inhibited by atropine. Hydergine also causes
central sedation and potentiates barbiturates. Hydergine has been used
to treat hypertension, particularly in Europe, and again the results
vary< 29 >. Some are quite encouraging, but the necessity of frequent dosage
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- - -.A utonomic Drugs - - - - - - - - - - - - - - - and the side-effects tend to Limit its usefulness. The European literature suggests that Hydergine will lower the blood pressure in about 50%
of hypertensives, and will be ineffective in about 35%. Wilkins< 3o> used
dihydroergokryptine, given I.V., to lower the blood pressure following
histamine injection in a case with pheochromocytoma. Animal experiments suggest that Hydergine inhibits ectopic rhythms during cyclopropane anesthesia, but Manning< 31 > found no significant protection in experimental coronary occlusion in dogs. Hydergine has been tried in a
variety of peripheral vascular disorders, in toxemia of pregnancy, and
angina pectoris. Final evaluation of its effectiveness is not yet possible.
Side-effects include nasal congestion, nausea and vomiting, postural hypotension, occipital headache, and gastric colic. Hydergine can be given
orally, sublingually, intramuscularly and if necessary intra-arterially (in
gangrene, etc.). Daily administration appears to yield the best results.
Dibenamine has been thoroughly studied pharmacologically by
Nickerson and Goodman <21 >. Two distinguishing features of the dibenamine-type blockade are its completeness and its duration. Extensive b~ock
ade may persist for 3 to 4 days after a single injection <32l, and once an
adequate block has been established, it cannot be overcome by massive
adrenergic stimulation. Dibenamine has been tried in Buerger's and
Raynaud's diseases, in acute arterial occlusion and in frostbite; it was
generally found to produce good peripheral vasodilatation and often
clinical improvement< 14 >. Dibenamine is too caustic to be given other
than by dilute intravenous drip, and despite the utmost care thrombosis
may occur at the site of injection. It may take several hours for the full
blocking effect to be realized, even after IV injection. Side effects such
as severe nausea and vomiting, visual impairment, loss of bladder control,
central nervous system stimulation (restlessness, confusion, occasional
convulsions) limit clinical use of the drug< 26>. Postural hypotension and
tachycardia are directly related to the adrenergic blockade. Dibenzyline is
said to be more potent in its blocking action and is, therefore, expected
to produce fewer undesirable reactions.
The value of chemical sympathectomy compared to other methods
of therapy is not possible to judge at the present time. Peripheral vascular diseases, including Raynaud's and Buerger's disease, diabetic gangrene, acrocyanosis, frostbite, acute peripheral arterial occlusion, causalgic state, and chilblains have all been treated with one or more of these
agents. All of them appeared to produce beneficial vasodilatation and
may offer great promise, but adequate controls were often lacking and
further investigation is indicated. Several of the adrenergic blocking
agents have been used in the diagnosis of adrenal medullary tumors, but
the reports usually deal with too few cases to allow objective evaluation.
Some investigators believe that cardiac arrhythmias can be prevented in
experimental animals by Dibenamine and Hydergine; others, however,
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found no protective action. Recent animal studies also suggest that in
certain kinds of experimental shock (hemorrhagic<n. Hl and traumatic<m ) ,
adrenergic blockade may increase survival, but no clinical results are yet
available.
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It is far too early to know how valuable chemical sympathectomy
may be in the treatment of hypertension. All of the above-mentioned
compounds have important disadvantages, such as too transient activity,
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---Autonomic Drugs - - - - - - - - - - - - - - - too many side effects, and the ever-present danger of postural hypotension. If sympathetic blockade is complete, then postural hypotension
is to be expected. This may be partly overcome by the use of abdominal
and leg binders, and preliminary observations indicate that patients may
in time compensate for postural changes in the presence of continued
blockade< 14 >. This adjustment is probably similar to that occurring after
extensive sympathectomy. Nor is it yet dear whether continuous therapy
is feasible because of the development of tolerance. At the moment,
studies are in progress in which Hexamethonium is being alternated with
compounds such as Apresoline and Veratrum alkaloids in an effort to
minimize both tolerance and toxicity. Undoubtedly short-term benefits
are possible, but for long-term therapy with ambulant patients, it is probable that none of the compounds presently under investiagtion offer the
answer to hypertension.
1.
2.
3.
4.
5.

6.
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8.
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Francis Staples Brien

Recently, a group of undergraduate medical students were advised
"when considering a hospital for internship, consider first the man
will be your chief". The students, graduates, and staff at the
.0. Medical School and Victoria Hospital are indeed fortunate to
hav as Professor of Medicine an individual who exemplifies those
qua ·ties that were in the mind of the speaker of those words.
pie
To
his
Ho

Professor Francis S. Brien was born in Windsor, Ontario and comd his elementary schooling there. He attended the University of
nto where he received his B.A. degree, and in 1933 was awarded
M.B. (medical) degree. After interning at the Toronto General
pital for three years, he took further post-graduate training in
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- - -.P ersonalitie.s------------------London, England, where he received through examination his M .R.C.P.
He returned to Canada and practiced internal medicine in Windsor until 1942 when he joined the R.C.A.M.C. He served overseas in England
and on the continent, finally attaining the rank of Lieutenant-Colonel.
For his heroic and excellent work he was mentioned in dispatches on
two occasions. Those who have heard Dr. Brien's lectures or have
worked with him are familiar with the wealth of experience he gained
during this period, and they associate many "gems" of medical knowledge with his anecdotes of army practice in Belgian hospitals.
Towards the termination of hostilities in Europe, he did further
work in the London (England) hospitals, and in 1945 was appointed
Professor of Medicine at the University of Western Ontario Medical
School. Soon after he was awarded a fellowship of the Royal College
of Physicians of Canada and also became a Fellow of the American
College of Physicians. Among his widespread medical interests, Prof.
Brien has given much of his time working on the executive of the Royal
College of Physicians and the Ontario Medical Association.
Dr. "Frank" Brien is a keen enthusiast of hunting and fishing, and
of late has become an even more ardent collector of stamps. He may
be classed with the few medical men who possess the rare ability of not
only being an outstanding medical teacher, but also a humanitarian. If
one were to evaluate Professor Brien's contribution to medicine, the
most outstanding dispensation would be the sound, common-sense type
of thinking he has imparted to the many students and internes who have
come under his tutelage. He possesses the ability and kindness that
allows him to treat the great, the ordinary, and the dregs of our society
with the same attitude of fairness and goodness; to him a patient is not
a group of signs and symptoms but a whole person.
Those of us who will soon leave the medical school and hospitals
will readily recall his fine manner, his pleasant approach at the bedside
or in the hallways, and his inimitable ability to wear those white,
buttonless "clinic" coats!
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Ventilation Studies:
Their Value As Pulmonary Function Tests
J. E. Merriman, M.D., C.M.
The value of vmtilation studies as pulmotJa1'y function tests
has not been app1'eciated by the majority of clinicians and it is
only recently that an awakening interest in this subject has developed. In this article, D1'. f. E. Me1'1'iman discusses the value
and limitations of these tests in clinical medicine.
THE first reported use of a test for puimonary function
PROBABLY
was in 1846 when Jonathan Hutchinson described the spirometer
1

and the value of vital capacity measurements in the diagnosis of pulmonary tuberculosis. During the last ten or fifteen years there has
been an increasing interest in the use of pulmonary function tests in
clinical medicine. Much has been learned from these tests, and their
value and limitations have now been fairly well established. 2 Such tests
are of value for several reasons. They allow an objectiv.e appraisal of
pulmonary function in problems of diagnosis and therapy in patients
with cardio-pulmonary disease. They furnish a quantitative measure
of pulmonary function so that candidates for thoracic surgery can be
carefully evaluated both from the immediate and the long term point
of view. Occasionally, they permit the early detection of pulmonary
abnormalities when other methods of study have failed to find evidence
of pulmonary disease. Finally, they allow a clearer concept of the
mechanism of the disease process when these tests indicate that a
specific function is altered.

Normal Pulmonary Function
Normal pulmonary function involves the removal of carbon dioxide
from , and the addition of oxygen to, the pulmonary capillary blood.
Three processes are involved in this gas exchange-ventilation, diffusion and circulation, and each should be accomplished with a minimum
expenditure of energy.

Circulation
Normally there is an adequate volume and distribution of pulmonary capillary blood. In disease the volume of blood flowing to the
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---Vetztilation Studies - - - - - - - - - - - - - - lungs may be reduced, as occurs after pulmonary embolism, or when
the total cardiac output is reduced. Shunts may be present so that some
blood bypasses the functional lung and enters the systemic circulation
at a low oxygen tension. These are present in cases of. congenital
arterio-venous fistulae where blood flows directly from the pulmonary
artery to the pulmonary vein. Functional shunts exist in certain cases
of bronchopneumonia where blood flows past alveoli that are not being
ventilated.

Diffusion
Perfect diffusion implies an unobstructed exchange of carbon dioxide and oxygen between the alveoli and the blood in the pulmonary
capillaries. Normally the mean partial pressure of carbon dioxide
(Pco2) is the same in the alveoli and in the pulmonary capillary blood
(arterial blood) . However, the mean partial pressure of oxygen (Po,)
in the alveoli is slightly higher, by up to 10 mm. Hg., than it is in the
arterial blood. One explanation given for this difference is that oxygen
is only one-thirtieth as diffusible as carbon dioxide. Abnormalities in
diffusion are seen in some cases of pulmonary fibrosis, where the fibrous
tissue, which is deposited between the alveoli and the capillaries, presents
a physical barrier to the transfer of oxygen. This is the syndrome of
alveolar-capillary block.; A higher mean alveolar Po2 is therefore necessary to maintain a normal Po2 of arterial blood and a normal oxygen
saturation. If the increased alveolar Po2 is not maintained, signs and
symptoms of anoxemia may result.
Ventilation
Ventilation studies are concerned with the volume of air which can
be moved in and out of the lungs as well as with the way this air is
distributed. Perfect distribution is present when all alveoli receive the
same volume of inspired ai r (proportional to their previous pre-inspiratory volume) so that, with perfect mixing, the concentration of the gas
in each alveolus is the same.
Subdivisions of the Total Lung Volume
The total volume of air that can be contained in the lungs is called
the total lung volume; this is made up of the vital capacity, which can be
measured directly with a spirometer, and the residual air, which must be
estimated by indirect pteans. The point of reference from which the various
subdivisions of the lung volume are measured is called the resting midposition, which is the level at the end of a normal expiration.4 The volume
of air which can be taken into the lungs starting from this position is
called the inspiratory capacity, while the amount that can be blown out
from the resting mid-position is called the expiratory reserve volume. The

140

U.W .O.

MEDICAL JOURNAL

amount of air contain.ed in the lungs at the end of a normal expiration is
called the functional residual air and is equal to the sum of the expiratory
reserve volume and the residual air.
The residual air is that volume of air remaining in the lungs after a
maximal expiration. Normally it constitutes about 20ro of the total
lung volume and is calculated by determining the volume of the functional residual air by one of two commonly employed procedures. In
Darling's open-circuit oxygen-dilution method expired air is collected
during seven minutes of pure oxygen breathing and is analyzed for its
nitrogen content. In the dosed-circuit helium-dilution method the patient continues to rebreathe a known concentration of helium in oxygen
until his functional residual air is thoroughly mixed with the heliumoxygen mixture. From the difference in helium concentration, which
is read from a sensitive meter before and after the test, the functional
residual air may be calculated.

Factors Affecting the Normal Vital Capacity
The vital capacity is the maximal amount of air that can be expired
after a maximal inspiration. It was Jonathan Hutchinson 1 who first showed
that the vital capacity varied with body weight. More recently, Baldwin
et aP, in a study of 90 normal individuals, devised formulae for predicting
the normal vital capacity, and they have shown that the vital capacity
varies directly with height and that it decreases slightly with age. However, for a given height and age, the range of the calculated vital capacity is quite large and may be as high as 1000 ccs.; whereas the variation
in the same individual from day to day is small. Thus a decrease of
300 ccs. in a patient's vital capacity probably signifies altered pulmonary
function. The vital capacity of a large-framed individual will be greater
than that of a small-framed individual of the same age and height. For
a given age and body build, weight is not as important as height in determining the vital capacity because an obese individual has the same
vital capacity as his lean counterpart.
When ventilation studies are performed, first in the sitting position
and then in the supine position, certain changes take place.

(1) There is a reduction of approximately 200 ccs. in the total
vital capacity, which is probably due to an increase in the total
pulmonary blood volume.
(2) The expiratory reserve volume is also reduced by an even
greater amount; when this is expressed as a percent of the total
vital capacity it is reduced from 40ro to 25%.
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---Ventilation S t u d i e s - - - - - - - - - - - - - - Factors other than position have been found to affect the expiratory
reserve volume; obesity, p regnancy and the wearing of a girdle are associated with a reduction in the sitting expiratory reserve volume6 •
It has been found that the total vital capacity does not correlate
well with pulmonary disability. A patient with pulmonary emphysema
will take twenty seconds to complete his vital capacity of 4500 ccs.,
whereas a normal individual will expire this same volume of air in four
seconds. Thus the importance of speed of ventilation was recognized
and various other tests were devised to quantitate this factor.
One of these is the maximum breathing capacity (M.B.C.) . This
test is performed by having the patient breathe both as quickly and as
deeply as possible for a twelve-second period, during which time the
total volume of air moved is measured by either a recording spirometer
or a large Tissot spirometer. Many factors influence the performance
of the M.B.C. The patency of the airways is the most important and
the other factors include: the rigidity of the bony thorax, the elasticity
of the lungs, the state of muscular co-ordination and the degree of cooperation. The M.B.C., which is expressed in liters per minute, has
proved to be a valuable test of ventilatory insufficiency. Other indices
.of ventilatory insufficiency have been devised, using the M.B.C. in conjunction with either the vital capacity or the minute volume of
ventilation. The capacity ratio, an index of the speed of ventilation is
M.B.C.
M.B.C. - Min. Vol.
C
.ty
.
The
breathing
reserve
ratio
is
M BC
.
V tta1 apaa
. . .

X

100.

Another test of the dynamic aspect of ventilation is the measurement of the timed vital capacity7 • If a vital capacity is energetically
performed and a spirometer tracing recorded on a fast-moving drum,
the resultant curve represents the maximum speed of air flow possible
for that individual. From such a tracing (illustrated in Fig. A) , it may
be seen that most of the air is expired during the initial phase of the
test. Normally about SO% of the vital capacity is completed in the first
second, and this amount is called the one-second vital capacity. As might
be expected, the one-second vital capacity and the M.B.C. show good
correlation in both normal and abnormal states. That the one-second
vital capacity is the usable and important part of the total vital capacity
can be seen when it is remembered that during exercise, the time available to complete each expiration is only about one second or less.
Oassification of Pulmonary Insufficiency
Let us now consider the application of pulmonary function tests
in clinical medicine. Pulmonary insufficiency can be classified into two
groups:
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(1) Ventilatory insufficiency, which will be discussed below and where
the chief symptom is dyspnea;
(2) Alveolo-respiratory insufficiency, where the abnormality in pulmonary function is in either distribution or diffusion and where
the symptoms are the result of anoxemia.
Ventilatory insufficiency can be subdivided into:
(a) Restrictive type
1. Thoracoplasty
2. Pulmonary resection
3. Kyphoscoliosis
4. Pulmonary fibrosis
5. Congestive heart failure
(b) Obstructive type
1. Asthma
2. Emphysema
3. Bronchostenosis
Baldwin, makes this classification on the basis of total lung volume
studies; the restrictive type shows a reduction in total lung volu(Ile and
vital capacity, and the obstructive type shows an increase in the r atio
of residual air to total lung volume. Gaensler7 differentiates restrictive
from obstructive ventilatory insufficiency using the total vital capacity
and the one-second vital capacity. He states that obstructive ventilatory
insufficiency is present when the one-second vital capacity as a percent of
the total vital capacity is reduced. These two methods of assessing obstructive ventilatory insufficiency, correlate well in severe cases of
chronic pulmonary emphysema. However, in less severe cases there may
be a normal ratio of residual air to total lung volume yet the percent
one-second vital capacity will be reduced.
Most cases of pulmonary insufficiency, however, show multiple
disturbances of function , and the best example of this is pulmonary
fibrosis. The fibrous tissue may be present in different anatomical areas
of the pulmonary lobule and a particular function will be disturbed by
the fibrous tissue in each location8 • Thus in the pleura or in the
parenchyma, the fibrous tissue would lead to a reduced total vital capacity, while peribronchially, ventilation studies would show a reduced
one-second vital capacity. Interstitial fibrosis would result in the syndrome of alveolar-capillary block, and vascular fibrosis would lead to
abnormalities of the pulmonary circulation.
Dyspnea, the chief symptom of ventilatory insufficiency, is defined
as an uncomfortable consciousness of laboured breathing occurring
when the ventilatory capacity cannot easily provide the actual ventilation.
MAY, 1953
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---Ventilation Studies - - - - - - - - - - - - - - Because this is a symptom involving sensation and the reaction to this
symptom, dyspnea is very difficult to study and to quantitate objectively.
With regard to the symptom dyspnea, we do not know its end-organ
in the lung, its afferent pathway, or the cortical centre for its appreciation. It does not seem to be related to a reduction of vital capacity, maximum breathing capacity, oxygen saturation, partial pressure of oxygen,
or to changes in pH. Moreover, dyspnea is not specifically a symptom
of heart and lung disease; it also occurs in obesity and pregnancy when
there is no evidence of cardiopulmonary disease.
The Pattem of V eorilation
Let us now consider the pattern of ventilation in normal individuals
and in patients with emphysema to see whether such studies will aid
in our understanding of dyspnea. Figure A shows a normal ventilation
tracing taken in the sitting position. The total vital capacity of 5100 ccs.
is normal for height and age. The expiratory reserve volume comprises
40% of the vital capacity and the inspiratory capacity 601o· The onesecond vital capacity is 4200 ccs. or 821o of the total. It will be seen
that the speed of air flow is initially very rapid and does not decrease
until approximately 4200 ccs. or 821o of the total vital capacity has been
expired. The resting mid-position has been reached in less than one
second after the commencement of the vital capacity determination.
This individual, then, is normally breathing in an area where he can
move air very rapidly. In other words, he is breathing on the steep part
of his vital capacity curve.
Figure B shows the pattern of ventilation in a patient with chronic
pulmonary emphysema. The total vital capacity of 3680 ccs. is slightly
reduced, the expiratory reserve volume comprises 45% and the inspiratory capacity 551o of the vital capacity. The important abnormality in
this patient, however, is the reduced one-second vital capacity which is
only 900 ccs. or 241o of the total. This patient is unable to attain the
high rates of air flow that the normal individual can. The resting midposition is not reached during the vital capacity determination until
about two seconds have elapsed. This patient is then breathing in an
area where he cannnot move air rapidly. In other words he is breathing
on the slope of his vital capacity curve.
The shape of the vital capacity curve depends upon the resistance
offered by the lungs and thorax to the flow of air. The respiratory
passages, especially the terminal bronchioles, contribute, to a large
degree, to this total pulmonary resistance. Resistance is also offered
by the lungs and thorax to a change in their shape incidental to the act
of breathing, but this is less important during inspiration than during
expiration.
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The Pattern of Ventilation in a Normal Subject and in a Patient with
Emphysema:
· A. Normal Ventilation Tracing.
Tracing was recorded from right to left. The two marks on the vital
capacity curve represent the one-second and two-second vital capacities which
constitute 82 % and 95 % of the total. The maximum breathing capacity (M.B.C.)
is shown at the extreme left. The lower pen, which is geared to the upper pen
is a 25 : 1 ratio, measures the total volume of air moved during the test. This
individual is breathing on the steep part of his vital capacity curve.
B. Tracing from a Case of Chronic Pulmonary Emphysema.
The one-second and two-second vital capacities are 24% and 44% of the
total. This patient is breathing on the slope of his vital capacity curve.
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---Ventilation S t u d i e s - - - - - - - - - - - - - - The work involved in moving a given amount of air will depend
upon the resistance offered to the flow of air and upon the time taken
to move this air. The work of breathing will thus be greater in a patient
with emphysema, who breathes on the slope of his vital capacity curve,
than in a normal individual who breathes on the steep part of his vital
capacity curve. Although quantitative data is meagre for the pulmonary
resistance and the work of breathing9, many investigators believe that
dyspnea is related in some way to the work of breathing.
The Use of Ventilation Studies
The majority of pulmonary function tests require elaborate and
expensive equipment and a trained technical team. Ventilatory function, on the other hand, can be assessed relatively easily and quickly with
a minimum of equipment. A recording spirometer, which can be operated at fast speed is most suitable for these studies because it allows
estimation of the tidal and minute volume, total and timed vital capacity,
and the maximum breathing capacity. A rough approximation of the
presence of obstructive ventilatory insufficiency can also be made if the
volume of the vital capacity is divided by the elapsed time. A normal
male will complete his vital capacity of 4000 ccs. in 4 seconds (ratio
1000:1) while an asthmatic will require 10 seconds to expire this same
volume (ratio 400:1). Gaensler7 has devised a simple and inexpensive
vitalometer with an electronic timing device with which one can quickly
determine the vital capacity and the one-second vital capacity.
It is interesting to note that the subcommittee on pulmonary function tests of the American Trudeau Society considered the following to
be the minimum requirements in evaluating a patient's pulmonary function10, "careful analysis of history; physical examination; a fluoroscopic
examination which attempts to evaluate the magnitude; speed and distribution of pulmonary ventilation; inspiratory and expiratory chest
X-rays; and a determination of the maximum breathing capacity." They
went on to say that these minimum requirements could be performed in
any hospital or sanitorium dealing with diseases of the chest.
Finally, there are definite limitations to pulmonary function tests.
There is no one single test of pulmonary function. These are physiological tests and do not make a pathological diagnosis, and they do not
localize disease in the lungs.
Summary
Pulmonary function tests allow an objective assessment of the state
of pulmonary function in patients with diseases of the heart and lungs.
Of the many tests available, those assessing ventilatory function are the
simplest to perform.
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When a vital capacity determination is made using a recording
spirometer with a fast paper speed, the tracing shows not only the speed
of ventilation and the total volume of air moved, but also the relation
of the resting mid-position of respiration to the vital capacity curve.
A classification of ventilatory insufficiency based on the measurements
of the total and one-second vital capacities is presented. It must be borne
in mind that a pulmonary function study will not tell where the lesion is,
what the lesion is, or even that a lesion exists, unless it interferes with the
normal function of the lungs.
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• The American Congress of Physical Medicine and Rehabilitation
is sponsoring the
FIRSf ANNUAL ESSAY AWARD
To stimulate interest in the field of physical medicine and rehabilitation, the
American Congress of Physical Medicine and Rehabilitation will award
annually a prize for an essay on any subject relating to physical medicine and
rehabilitation. The contest, while open to anyone, is primarily directed to medical students, internes, residents, graduate students in the pre-clinical sciences
and graduate students in physical medicine and rehabilitation.
Any subject of interest or pertaining to the field of physical medicine and rehabilitation may be submitted.
Manuscripts must be in the office of the American Congress of Physical Medicine and Rehabilitation, 30 N. Michigan Ave., Chicago 2, not later than
June 1, 1953.
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WHO Notes:
Influenza Today
A. M. M. Payne, MD.: M.R.C.P.*

The World Health Organization · plays an important role in world
medicine today and often people do not realize the importance of the work
carried out by this important specialized agency of the U.N. With the
publication of this article, the Editon hope that we can bring to our rellllers
timely and interesting articles of the work of W.H.O.
Influenz~ is news. Each time an influenza epidemic appears on any large
scale - and this happens every two
or three years - frequent reports in
the Press reflect public interest and
anxiety. Memory of the 1918-19 pandemic dies hard, and it is right that
it should live since we do not know
what combination of circumstances
brought it about, nor whether it will
ever occur again. Nevertheless, no subsequent epidemic has been on such a
scale or of such severity as to justify
comparison with that disaster. And
yet the comparison has been made in
some reports even in this year's mild
epidemic, whereas other reports have
contained too optimistic views on the
prospects for controlling the disease.
Such inaccuracies are perhaps inevitable in this age of speed, for there is
not time to double-check the accuracy
of a report on an incident 5,000 miles
away when the public demands that
the news should be on the breakfast
table next morning; and the objective
assessment of new control measures
is a slow process requiring years of
patient observation in which there is
no place for impatient enthusiasm.

The purpose of this article is to give
an account of this year's epidemic up
to the end of January, based on confirmed reports, illustrating the way in
which the World Health Organization
is helping to tackle the problem of influenza, together with some speculations regarding the future- prospects
for controlling the disease.
But first it is necessary to consider
some technical facts. Three main types
of the virus of influenza have so far
been discovered; the two most important of them - A and B - comprise
several sub-groups which in the case
of Virus A may differ so much as to
afford little or no protection following
infection or vaccination from subsequent infection by a virus of a different sub-group. During an epidemic
the virus breeas true within certain
limits, that is to say an outbreak due
to one strain of Virus A is not related
to one due to a different strain, even
if it occurs nearby and at about the
same time. From time to time new
strains appear which may be quite different from previously known strains
both as far as protection by vaccination

•Dr. A_ M. M. Payne is associated with the Division of Communicable Disease Services. World
Health Organization.
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is concerned and also in their ability
to cause epidemics and to kill. The
consequence of these facts are that
epidemiological reports can only be
correctly interpreted in terms of laboratory studies of the viruses responsible;
that successful vaccination against influenza depends on knowledge of the
virus causing the epidemic; and that
continuous vigilance is necessary to
detect new and potentially dangerous
strains at the earliest possible moment.

In 1952, laboratories in the WHO
network again isolated an A-prime
strain (Liverpool subtype) in South
Africa in May, and the similarity of
the circumstances to those of 1950
caused the World Influenza Centre to
issue in June a cautious warning that
there might be an outbreak due to this
strain this winter, but that it would
quite probably not be clinically severe
since partial immunity may have peri ted from the 1950-51 epidemic.

Epidemiology
It was with these facts in mind that
in 1947 the Interim Commission of
the W odd Health Organization initiated a world-wide network of influenza laboratories by setting up the
World Influenza Centre in London for
the study and comparison of strains of
virus isolated in different parts of the
world. This was a logical development of a similar network previously
set up by the Armed Services Commission on Influenza in the United States
of America.. A second reference laboratory in New York, known as the
Strain Study Centre for the Americas,
is co-ordinating the work in the Americas. The world network now includes
55 laboratories in 44 different countries. Many more laboratories are cooperating informally.

In the latter half of December influenza was reported in the United
States of America in the State of Missouri, the virus being similar to Scandinavian 1951 A-prime virus. Numerous isolations of virus throughout the
country confirmed that an A-prime
virus was responsible for the outbreak.
although, as is frequently the case, a
few sporadic cases of Influenza B were
detected. The epidemic continued to
increase during the first three weeks
of January, with a small increase in
the number of deaths attributed to influenza and pneumonia. Towards the
end of January there were indications
that in some states at least the epidemic had reached its peak.

The work of these laboratories continues summer and winter, for new
strains may appear during the summer and the strains causing epidemics
during the winter in the southern
hemisphere may spread to the northern hemisphere to cause outbreaks
there a few months later. This apparently occurred during the 1950-51
outbreak when a strain of A-prime
virus isolated in South Africa and Australia during June was found to be
identical with one causing a severe
outbreak in Liverpool in the following
January. This became known as the
Liverpool subtype; another simultaneously present in Western Europe was
called the Scandinavian subtype.

MAY, 1953

In the United Kingdom a mild form
of influenza spread across southern
England and Wales in the first half
of January, and began to appear as
localized outbreaks in the midlands
and north in the third and fourth
weeks. The epidemic had not reached
Scotland by the end of the month.
Several strains of virus have been
identified as A-prime resembling the
1951 Scandinavian type and generally
similar to the strains isolated in
the U.S.A. but slightly different
from the 1953 strains from Paris and
Switzerland.
Outbreaks were also reported beginning in December in various parts of
the Pacific region, including the Philippines, Hawaii and Japan, where the
vi rus was identified as A-prime.

149

---WHO N o t e s - - - - - - - - - - - - - - - The true interpretation of the epidemiological data must await the results of further careful studies and
comparisons of the viruses isolated in
various parts of the world. However,
it is clear that the viruses responsible
for this epidemic are of the A-prime
type and closely related to strains isolated in 1950-51.
Vaccination
This is fortunate because several
large-scale trials of influenza vaccines
had been planned this winter by national organizations in the U.S.A.,
Canada, the United Kingdom and the
Netherlands. These would have been
of much less value if there had been
no epidemic or if the responsible virus
had shown unusual characteristics. As
it is, important information may be
hoped for from these trials both as
to the effectiveness of the vaccines
used and how best to use them.

not be achieved at present.· There are
several difficult problems which must
be solved first.
Primarily there is the unpredictability of the influenza virus, which
shows no stability in nature. This is
being tackled, as already explained by
an "intelligence service", in the shape
of the WHO network of laboratories
which is constantly studying changes
in the virus as they appear, and this,
it is hoped, may eventually lead to the
ability to forecast epidemics with reasonable reliability.
Further, a great deal remains to be
learnt about the best methods of pro·
ducing, testing and using vaccines.
There is, for example, a relatively new
type of vaccine under test which appears to have advantages in the degree
and duration of immunity produced,
together with economy in the amount
of virus needed. There is no doubt
that if this is confirmed and the safety
of the vaccine proven it will rt:present
a major advance; however, at the present time it must be con:~· fered
experimental.

Unfortunately vaccination against influenza produces neither as lasting nor
as complete an immunity as does, for
example, vaccination against smallpox.
In controlled trials in the past the unprotected individuals have been atThe use of influenza vaccines pretacked about four times as often as
sents
a number of problems. It is
the inoculated, but a number of the
latter still become ill with the disease, dearly impracticable to vaccinate the
and the degree of protection has prob- whole population each year owing to
ably waned considerably after a year. the great expense and difficulties of
It must be stressed that the vaccines such a scheme. The questions are whom
at present under test lend no hope of to inoculate and when. The answers
being able to eliminate the disease; the will depend a great deal on local conbest that can be hoped for is to limit ditions and economy. It is hoped that
the effects of an epidemic by reducing some guidance on this will be forththe number of people who fall sick coming as a result of the trials at
and hence diminishing the economic present in progress.
effects of the epidemic which are sometimes serious. All claims of the sucAn important function of all health
cessful control of influenza must be authorities is the protection of the pubinterpreted in this strictly limited sense. lic from dangerous, inferior or inIf by control measures the effect of active products. To effect this it is
an epidemic of influenza could be re- necessary to lay down tests and standduced throughout a country to one- ards to which products must conform.
tenth of what it would otherwise be, Although this has been done in some
that would indeed be a success. It can- countries, there are, as yet, no uni-
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versally agreed standards for influenza
vaccine which are needed before it can
take its place as a fully recognized
preventive agent.
To sum up it may be stated that
there is good reason to believe that
influenza vaccines will play a principal role in lessening the effects of influenza epidemics in the future. However, they give no hope of eliminating

influenza altogether, and indeed further research and cateful observations
are needed before the best methods
of preparation and use of vaccines
can be decided.
Nevertl\eless, a great deal of research work is in progress and it may
be hoped that solutions to many problems will be found in the not far distant future.
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• Post-Graduate Symposium of the Basic Sciences
Related to Anesthesiology

June 8-12, 19S3
Will be held at the
UNIVERSITY OF PITTSBURGH SCHOOL OF MEDIONE
Pittsburgh, Pa.
Registration fee $2500
Th"s course will be limited to 50 participants. For full particulars write:
~ •Chairman of the Committee on Graduate Medical Education
UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE
3941 O'Hara Street, Pittsburgh 13, Pennsylvania

• Schering Award Competition, 1953
Three $500 prizes will be awarded for the papers judged most distinctive
by a panel of leading medical authorities on the subjects covered.
Titles of the general topics are:
1. Antihistaminic Treatment of Upper Respiratory Allergies and Infections.
2. Hormone Therapy of the Degenerative Diseases.
3. New Concepts in the Treatment of Peptic Ulcer.
This year numerous $100 Deans' Awards will be presented and in each
school where several students compete, the Dean is invited to select the most
meritorious paper.
The deadline for entry forms specifying the title chosen by the student is
July 1. The actual -manuscript must be postmarked by October 1 .
Information and instructions for the competition are available from :
THE SCHERING CORPORATION
2 Broad Street, Bloomfield, New Jersey
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THE SYMPTOMS AND TREATMENf OF ACUTE POISONING

PEDIATRICS IN
GENERAL PRACTICE

G. H. Lucas, Professor of Pharmacology,
University of Toronto. P. 380. Clarke,
Irwin & Co., Toronto, 1952.

Jonus G. Hughes, B.A ., M.D., Professor
oj Pediatrics, University of T ennessee,
College of Medicine, Memphis. 1st
edition, P. 738, illust. McGraw-Hilt
Book Compa11y of Canada limited,
1953.

This is a practical book in toxi
cology designed both for students and
medical practitioners. It reflects the
wealth of experience gained by Doctor
Lucas over a period of many years.
After general considerations, the
useful drugs and apparatus which the
physician will require to treat the patient, both before and after admission
to hospital, are discussed. They are
treated separately in regard to indications, dose and mode of administration . Very practical information is
g iven in the use of emetics and gastric lavage. The directions for the use
of the latter are especially good. One
chapter is devoted to the problem of
poison ing in children. He stresses the
falsity of prescribing burned toast as
a substitute for activated charcoal. The
importance and methods of collection
of samples for the analyst, such as
stomach wastings, etc., are stressed.
The greater part of the book is taken
up with " Cases of Poisoning". This
includes the signs, symptoms and treatment of individual poisons. The material is arranged in an orderly and
practical manner . All the newer
poisons, such as "Toxaphane", "Parathion ", etc., and antidotes such as
B.A.L. are included.
The book is an excellent contribution to the diagnosis and treatment
of poisons. Medical students and practi tioners will find it invaluable.
-R. A. WAUD, M.D.
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This up-to-date book on pediatrics
is a boon to the general practitioner
and to the medical student. In 738
pages the common problems of pediatrics in general practice are presented
in a real and creative manner. Dr.
Hughes gives us a dear conception of
the disease processes and presents a
rational and practical routine of management. The remarkable clarity of
thought makes reading very enjoyable
and easy, but there is no oversimpl ification .
This book is different, in that, it
is not too extensive to be laborious,
however, ooe might criticize it, in that,
there is a lack of detail on the more
obscure problems in pediatric medicine, but this criticism is essentially
unfounded because great detail would
take away from the dearness and directness which is so characteristic of
the text. There is an extensive bibliography at the end of each chapter
for those who would voice the above
criticism.
The author, on the other band, is
academic enough to present his readers with basic sound principles and
be does this in his first four chapters
on the new born infant, infant nutrition, nutritional disturbances and problems of fluid and electrolyte balance.
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With such a background the reader
can better assimilate the content of
the chapters in which pediatric problems are organized into systems. Pre·
ventive medicine with immunization
and control of infectious diseases so
important in pediatrics is stressed and
some emphasis is placed on subjects
such as allergy and the psychological
aspect of childhood .
The excellent pbotog.raphs, x-ray
photographs and diagrams are essential to a vivid presentation. The
spacing and headings on every page
give the book still another advantage.
- T. RICHARDS, '53.

LOGAN TURNER'S DISEASES OF
THE NOSE, THROAT AND EAR

Ed. William Guthrie. MacMillan Co.,
Canada, P. 478, illust. 1952.
This is a complete revision of a
textbook which has enjoyed great popularity in the past. The fourth edition,
edited by Dr. Logan Turner of Edinburgh, was published in 1936 and has
been out of print for some years.
Dr. Douglas Guthrie, the sole survivor
of those contributing to earlier editions, is the editor of this fifth edition
which like former ones, is planned
primari ly for senior medical students
and practitioners. It contains fundamental knowledge upon which the
specialist may build. ··
In the manner of previous editions,
the book is divided into seven sections:
Diseases of the Nose, Affections of the
Paranasal Sinuses, The Pharnyx and
Nasopharnyx, The Larnyx, Peroral
Endoscopy, Diseases of the Ear and a
brief section on The Sulphonamides
and Antibiotics. This last section replaces one on formulae for use in the
diseases discussed.
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The content of the book, although
similar in style to that of previous
editions, has many additions and bas
been in places drasticaiiy revised.
Beside the sections on therapeutics, the
discussion of disorders of voice, teaching of the deaf and artificial hearing
aids are among those which have been
greatly changed. Modern methods of
endoscopy are discussed. There are
numerous small changes throughout
the text such as the replacement of a
discussion of nasal neuroses by one on
allergy and similar conditions in the
nose.
Descriptions of clinical conditions
are concise, but contain adequate information for the person encountering
them in general practice. Short notes
concerning the embryological and postnatal development of the paranasal
sinuses, tonsils, middle ear and external ear are helpful in understanding
disease processes of these organs. The
es entia! facts about treatment are
present, but the many fine details
which are learned by practical experience are omitted. To further help student , many forms of treatment are
visualized in illustrations. The entire
rna s of information is handled in such
a way that there is little overlapping.
The subject matter is similar to that
in other such textbooks, although disease of the skin over the nose and
ear are not discussed nearly as fully
as in most ear, nose and throat textbooks. There is no bibliography or
references.
All in all, this is a moderate sized
book which will be welcomed by students and practitioners as an easily
read, authoritative textbook upon the
nose, throat and ear.
-

LILLIAN

M.

BEATTIE,

'54.
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Alumni News:
• Dr. R. G. Knipe, lecturer in the
Department of Clinical Preventive
Medicine and Director of the ElginSt. Thomas Health Unit has recently
resigned the above posts and has
accepted the Directorship of the
County Health Unit, Batavia, N.Y.

Hospital, Baltimore, and in New York
City. In 1924 be returned to London
and worked with the late Dr. W. J.
Stevenson. During the following years,
Dr. Peevers gained local, national and
international repute for his surgical
skill.

J, M.,.,..u,, . . .

• Howard C. Moloy '27, died March
13 at the age of 60. Dr. Moloy was
assistant attending obstetrician and
gynecologist at the Columbia-Presbyterian Medical Centre and a member
of the teaching staff at the College of
Physicians and Surgeons, Columbia
University.

• William T. Banting '92, died at
his home in Lucan, Ontario, on March
16 at the age of 85. After graduation
Dr. Banting practised in Lexington,
Michigan, for 10 years before he established his practice in Lucan.
• Manley G . Peevers '21, died March
17 at the age of 57 following a brief
illness. Well known as a sportsman
and a surgeon, Dr. Peevers was on the
medical staff at St. Joseph's Hospital,
London, and held the post of Alumni
Representative on the University's
Board of Governors.
After graduating he did three years'
post-graduate work at Johns Hopkin

He gained international recognition
for his research and writings in his
chosen field . Most of his research was
carried out in the field of Roentgen
pelvimetry and it was through this
work that the Caldwell-Moloy classification of female pelves was developed. Much of Dr. Moloy's work
had to do with perfecting radiological
tochniques to foresee possible complications in childbirth.

• Interne placements were announced on March 16, much to the interest of
all medical undergraduates, and particularly to the concern of those preparing
for the "Councils". The Meds of 'H are by no means leaving the Western
fold, but are now entering upon greater vistas of achievement and from those
who are following in their footsteps, we wish them the best of luck and
au revoir- 'H!

NAME

HOSPITAL

BAGSHAW, John .. ................... ....................... Hamilton General, Hamilton, Ont.
BOLES, Murray ..... .................. ............... .. .................................. Grace, Detroit, Mich.
BOYES, James .......................... .................. ..... ..... ...... .............. Mercy, Baltimore, Md.
BOYES, Truman ................................................. ....... St. Vincents, New York, N.Y.
BRUNER, George.................................................. .......... St. Joseph's, London, Ont.
CARROLL, Edwin ..... ..... .... .. ......................... ...... ....... ............ Victoria, London, Ont.
CLANCY, Patrick.. ......................................... .... ............... St. Joseph's, London, Ont.
CLIFf, Allan ................................................................. .. ... St. Joseph's, Lon.d on, Ont.
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CRANG, Donald ...................................................... Toronto General, Toronto, Ont.
CROWLEY, Patrick .............................................. Mt. Carmel Mercy, Detroit, Mich.
DENNIS, Marion .................................................................... Victoria, London, Ont.
DOUGALL, Ross ........................ .. .......................................... Victoria, London, Ont.
FODERICK, Peter ................................................................ Ancker, St. Paul, Minn.
GARWOOD, Gordon ....................................................... St. Joseph's, London, Ont.
GRANT, James ............................................... Vancouver General, Vancouver, B.C.
HANNAH, Walter ................................................ Toronto Western, Toronto, Ont.
HOLMES, Robert... ................... George Washington University, Washington, D.C.
HUNTER, Andrew ................................................ Toronto Western, Toronto, Ont.
JAMES, Kenneth ...................................................................... Victoria, London, Ont.
KENT, R. W .. .................................................... Brantford General, Brantford, Ont.
KENT, Wallace ............ ................ .... ..... ............... .. ...... .... St. Joseph's, London, Ont.
KOVAL, Andrew .................................................................... Victoria, London, Ont.
LANSING, Allan ... ............................................ ..................... Victoria, London, Ont.
LaROCQUE, Raymond ............................ .. ...................... Hotel-Dieu, Windsor, Ont.
LOCKWOOD, Charles ............................... ....................... St. Joseph's, Toronto, Ont.
LOVEGROVE, Thomas .......................................................... Victoria, London, Ont.
McCONNELL, John ....................................... Vancouver General, Vancouver, B.C.
McJANNETT, William ..... .......... ............. University of Alberta, Edmonton, Alta.
McLEISH, John ................................................................. St. Joseph's, London, Ont.
MARCHUK, Peter.. ............................ ......... ............ Royal Victoria, Montreal, Que.
MARRIOTT, Douglas ................................... ..... Hamilton General, Hamilton, Ont.
NICHOL, James .......... ............................................................................ Not Interning
NICHOLSON, Robert.. .......................................................... Victoria, London, Ont.
OLSON, Clifford .............................................. Vancouver General, Vancouver, B.C.
ONERHEIM, William ................................................ Regina General, Regina, Sask.
PATTERSON, Thomas ..................................... ...... ............... Victoria, London, Ont.
POWER, Lawrence ........ ................. ............ ... .................... St. Joseph's, London, Ont.
PROUD, John .................................................... Hamilton General, Hamilton, Ont.
RICHARDS, Burke .............................................. Montreal General, Montreal, Que.
RICHARDS, Jo-Anne ............................................................. Victoria, London, Ont.
RICHARDS, Terrence ........................................................... Victoria, London, Ont.
RICHARDSON, Stanley ........ George Washington University, Washington, D.C.
ROBINSON, Martio ................................................Toronto General, Toronto, Ont.
RUNDLE, Alan ........................................................................ Victoria, London, Ont.
SANBORN, Shannon .......... ..... ............................ Toronto Western, Toronto, Ont.
SCHILLER, Honore ......................................................... Hotel-Dieu, Windsor, Ont.
SHAW, Robert .................................................................. St. Joseph's, Toronto, Ont.
SMITH, Delbert.. ................................................ Hamilton General, Hamilton, Ont.
SMOUT, Marvin ..................................................................... Victoria, London, Ont.
STAPLEFORD, Edmund ....... George Washington University, Washington, D.C.
SWARTZ, Gerald ................................................ Montreal General, Montreal, Que.
TAYLOR, James ...................................... .................... Regina General, Regina, Sask.
TEW, William ........................ .... ...... ... ................... Toronto General, Toronto, Ont.
THOMPSON, Robert.. .... .. .................................................... Victoria, London, Ont.
TWELVES, John .................. .. ............................ Hamilton General, Hamilton, Ont.
WALKER, John ..................................................................... Victoria, London, Ont.
WALL, Charles ............................................................... St. Joseph's, London, Ont.
WALSH, Milton .................... ............................................ St. Joseph's, London, Ont.
WHITE, James .................................................... Hamilton General, Hamilton, Ont.
ZAHARUK, Walter.. ................ .. .................................... St. Joseph's, London, Ont.

MAY, 1953

155

UNIVJ!IlSITY OF Wl!STI!IlN ONTAJUO MEDICAL JOURNAL

Dial 2-4138

For Insurance

of All Types
Call

BEN
BRYANT
''YoUr Druggist"
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Our Motto:

" PRESCRIPTIONS FIRST"

In addition to a thoroughly modem
ecieotific approach to the patient's problems. Homewood 11tl'e88ell the advantage
of a homelike environment for nervoue
and mild mental dieorden, peychooeoroeill
and a limited number of habit caeee and
caeee of eenility all under the individual
care of Psychiatric Specialillte and Pbyeiciane and a competent P sychiatric staJI'.
All modem therapy ill available. including P sycbotherapy.lnsulin. Electroehock
and Electronarcosill combined with excellent Occupational and Recreational
faciliti.ee. Homewood ill eituated in over
90 aCI'ell of beautiful woode and 8owerinf:
lawna. and providee accommodation for
over 200 patientll. Pbyeicianll and tboee
intereeted are invited to villit Homewood
or to write for an illustrated Fold« to:
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ROY WILLIAMS

10 WRIGHT BLDG.
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A. L MaciiNNON, M.l., Meclcal S!!pt.
THE HOMEWOOD SANITARIUM OF
GUELPH, ONTARIO, LIMITED

